
Lusutrombopag
CAS No. 1110766-97-6
Lusutrombopag( S-888711 )
Catalog No. M10412 CAS No. 1110766-97-6
An orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 87 | In Stock |
![]() ![]() |
5MG | 151 | In Stock |
![]() ![]() |
10MG | 241 | In Stock |
![]() ![]() |
25MG | 466 | In Stock |
![]() ![]() |
50MG | 677 | In Stock |
![]() ![]() |
100MG | 954 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameLusutrombopag
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist.
-
DescriptionAn orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist; acts selectively on the human thrombopoietin receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels; Other Indication Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsS-888711
-
PathwayImmunology/Inflammation
-
TargetCD110
-
RecptorCD110
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number1110766-97-6
-
Formula Weight591.5458
-
Molecular FormulaC29H32Cl2N2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 33 mg/mL
-
SMILESO=C(O)/C(C)=C/C1=C(Cl)C=C(C(NC2=NC(C3=CC=CC([C@@H](OCCCCCC)C)=C3OC)=CS2)=O)C=C1Cl
-
Chemical Name2-Propenoic acid, 3-[2,6-dichloro-4-[[[4-[3-[(1S)-1-(hexyloxy)ethyl]-2-methoxyphenyl]-2-thiazolyl]amino]carbonyl]phenyl]-2-methyl-, (2E)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim ES. Drugs. 2016 Jan;76(1):155-8.
2. Sakamaki A, et al. Clin J Gastroenterol. 2017 Jun;10(3):261-264.
molnova catalog



related products
-
Hetrombopag
Hetrombopag is a potent, selective, orally-active Thrombopoietin (TPO) receptor agonist.
-
Lusutrombopag
An orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist.